{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:54:05Z","timestamp":1790628845220,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.arcmed.2005.01.004","type":"journal-article","created":{"date-parts":[[2005,5,29]],"date-time":"2005-05-29T07:18:06Z","timestamp":1117351086000},"page":"250-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Complementary Therapies for Diabetes: The Case for Chromium, Magnesium, and Antioxidants"],"prefix":"10.1016","volume":"36","author":[{"given":"Fernando","family":"Guerrero-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Rodr\u00edguez-Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2005.01.004_bib1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States, 1990\u20131997. Results of a follow-up national survey","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2005.01.004_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2337\/diacare.26.4.1277","article-title":"Systematic review of herbs and dietary supplements for glycemic control in diabetes","volume":"26","author":"Yeh","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/diaspect.15.4.262","article-title":"Interactions between complementary therapies or nutrition supplements and conventional medications","volume":"15","author":"Shane-McWhorter","year":"2002","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.arcmed.2005.01.004_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archfami.8.5.386","article-title":"Chromium. Friend or foe","volume":"8","author":"Porter","year":"1999","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib5","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.2337\/diacare.25.2007.S133","article-title":"Unproven therapies (Position Statement)","volume":"25","author":"American Diabetes Association","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/07315724.1998.10718729","article-title":"Micronutrients as nutriceutical interventions in diabetes mellitus","volume":"17","author":"Cunningham","year":"1998","journal-title":"J Am Coll Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2005.01.004_bib7","first-page":"S44","article-title":"Nutrition recommendations and principles for people with diabetes mellitus","volume":"24","author":"American Diabetes Association","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/07315724.1998.10718801","article-title":"Chromium research from a distance. From 1959 to 1980","volume":"17","author":"Mertz","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0026-0495(92)90318-5","article-title":"The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin dependent diabetes","volume":"41","author":"Abraham","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.arcmed.2005.01.004_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0003-9861(57)90228-X","article-title":"A glucose tolerance factor and its differentiation from factor 3","volume":"72","author":"Schwartz","year":"1957","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.arcmed.2005.01.004_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2337\/diaspect.14.3.133","article-title":"Select vitamins and minerals in the management of diabetes","volume":"14","author":"O'Connell","year":"2001","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.arcmed.2005.01.004_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/07315724.1998.10718802","article-title":"Chromium, glucose intolerance and diabetes","volume":"17","author":"Anderson","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/07315724.1999.10718821","article-title":"Mechanisms of chromium action. Low-molecular-weight chromium-binding substance","volume":"18","author":"Vincent","year":"1999","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diab.46.11.1786","article-title":"Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes","volume":"46","author":"Anderson","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2005.01.004_bib15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jn\/132.6.1107","article-title":"Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JRC-LA corpulent) rats","volume":"132","author":"Cefalu","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1753-4887.1998.tb06132.x","article-title":"Interaction of chromium with insulin. A progress report","volume":"56","author":"Mertz","year":"1998","journal-title":"Nutr Rev"},{"key":"10.1016\/j.arcmed.2005.01.004_bib17","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1021\/bi963154t","article-title":"Chromium oligopeptide activates insulin receptor tyrosine kinase activity","volume":"36","author":"Davis","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.arcmed.2005.01.004_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/07315724.2001.10719034","article-title":"Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus","volume":"20","author":"Anderson","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jn\/130.5.1274","article-title":"High chromium yeast supplementation improves glucose tolerance in pigs by decreasing hepatic extraction of insulin","volume":"130","author":"Guan","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib20","first-page":"183","article-title":"Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus","volume":"8","author":"Ravina","year":"1995","journal-title":"J Trace Elem Exp Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/diacare.17.12.1449","article-title":"Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM","volume":"17","author":"Lee","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02785287","article-title":"Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors","volume":"55","author":"Thomas","year":"1996","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1079\/BJN19920078","article-title":"Chromium supplementation in impaired glucose tolerance of elderly. Effect on blood glucose, plasma insulin, C-peptide, and lipid levels","volume":"68","author":"Uusitupa","year":"1992","journal-title":"Br J Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ajcn\/54.5.909","article-title":"Supplemental-chromium effects on glucose, insulin, glucagons, and urinary losses in subjects consuming controlled low-chromium diets","volume":"54","author":"Anderson","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0271-5317(05)80421-X","article-title":"Lipid lowering effect of dietary chromium (III)-nicotinic acid complex in male athletes","volume":"13","author":"Lefavi","year":"1993","journal-title":"Nutr Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-8227(95)01097-W","article-title":"Effect of chromium supplementation on fasting insulin levels and lipid parameters in healthy non-obese young subjects","volume":"28","author":"Wilson","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.arcmed.2005.01.004_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07315724.2001.10719050","article-title":"Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program","volume":"20","author":"Volpe","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ajcn\/78.1.192","article-title":"Chromium picolinate and type 2 diabetes","volume":"78","author":"Kalman","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib29","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.2337\/diacare.27.2007.S36","article-title":"Nutrition principles and recommendations in diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jn\/130.4.715","article-title":"The biochemistry of chromium","volume":"130","author":"Vincent","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib31","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2337\/diacare.27.11.2741","article-title":"Role of chromium in human health and in diabetes","volume":"27","author":"Cefalu","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/biof.5520110301","article-title":"Is chromium a trace essential element?","volume":"11","author":"Stearns","year":"2000","journal-title":"BioFactors"},{"key":"10.1016\/j.arcmed.2005.01.004_bib33","first-page":"4","article-title":"Magnesium. Metabolism and requirements","volume":"12","author":"Lopez Martinez","year":"1997","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.arcmed.2005.01.004_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00404136","article-title":"Magnesium and glucose homeostasis","volume":"33","author":"Paolisso","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2005.01.004_bib35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0895-7061(96)00342-1","article-title":"Hypertension, diabetes mellitus, and insulin resistance. The role of intracellular magnesium","volume":"10","author":"Paolisso","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2005.01.004_bib36","first-page":"1","article-title":"Magnesium and glucose metabolism","volume":"49","author":"Lefebvre","year":"1994","journal-title":"Therapie"},{"key":"10.1016\/j.arcmed.2005.01.004_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s005920200036","article-title":"Low serum magnesium levels and metabolic syndrome","volume":"39","author":"Guerrero-Romero","year":"2002","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.arcmed.2005.01.004_bib38","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/archinte.159.18.2151","article-title":"Serum and dietary magnesium and the risk for type 2 diabetes mellitus","volume":"159","author":"Kao","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib39","first-page":"355","article-title":"New data about the effect of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure)","volume":"6","author":"Kisters","year":"1993","journal-title":"Magnes Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1056-8727(00)00127-6","article-title":"Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values","volume":"14","author":"Guerrero-Romero","year":"2000","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.arcmed.2005.01.004_bib41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/106002809302700619","article-title":"Magnesium and diabetes. A review","volume":"27","author":"White","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.arcmed.2005.01.004_bib42","first-page":"431","article-title":"Plasma, erythrocyte and platelet magnesium in essential hypertension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease","volume":"86","author":"Grif\u00f2","year":"1995","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0188-4409(01)00298-3","article-title":"Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes","volume":"32","author":"Rodr\u00edguez-Mor\u00e1n","year":"2001","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2337\/diab.41.1.35","article-title":"Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications","volume":"41","author":"Grafton","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2005.01.004_bib45","first-page":"139","article-title":"Magnesium in diabetes mellitus","volume":"54","author":"de Valk","year":"1999","journal-title":"J Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib46","first-page":"25","article-title":"Magnesium status and ageing. An update","volume":"11","author":"Durlach","year":"1998","journal-title":"Magnes Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(96)01201-6","article-title":"Foot pathology and risk factors for diabetic foot disease in elderly men","volume":"32","author":"Bres\u00e4ter","year":"1996","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.arcmed.2005.01.004_bib48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.1996.00440100029005","article-title":"Hypomagnesemia and diabetes mellitus. A review of clinical implications","volume":"156","author":"Tosiello","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib49","first-page":"2415","article-title":"Intracellular magnesium of mononuclear cells from venous blood of clinically healthy subjects","volume":"48","author":"Reinhart","year":"1988","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2005.01.004_bib50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/07315724.1989.10720330","article-title":"Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency","volume":"8","author":"Ricen","year":"1989","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02590769","article-title":"Serum and erythrocyte magnesium levels in type I and type II diabetics","volume":"22","author":"Vanroelen","year":"1985","journal-title":"Acta Diabetol Lat"},{"key":"10.1016\/j.arcmed.2005.01.004_bib52","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1093\/ajh\/6.4S.123S","article-title":"Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of syndrome X","volume":"6","author":"Resnick","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2005.01.004_bib53","first-page":"189","article-title":"Elevated serum concentration of tumor necrosis factor-alpha is linked to low serum magnesium levels in the obesity-related inflammatory response","volume":"17","author":"Rodr\u00edguez-Mor\u00e1n","year":"2004","journal-title":"Magnes Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.ijo.0801954","article-title":"Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects","volume":"26","author":"Guerrero-Romero","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.arcmed.2005.01.004_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02454195","article-title":"Magnesium-deficiency elevates circulating of inflammatory cytokines and endothelin","volume":"110","author":"Weglicki","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.arcmed.2005.01.004_bib56","first-page":"323","article-title":"Effects of ATP-MgCl2 administration in hypovolemic dogs","volume":"41","author":"Katircioglu","year":"1999","journal-title":"Panminerva Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib57","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.RES.74.5.1009","article-title":"Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition","volume":"74","author":"Weglicki","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2005.01.004_bib58","first-page":"R764","article-title":"Pathobiology of magnesium deficiency. A cytokine\/neurogenic inflammation hypothesis","volume":"263","author":"Weglicki","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.arcmed.2005.01.004_bib59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4439(00)00018-1","article-title":"Inflammatory response following acute magnesium deficiency in the rat","volume":"1501","author":"Malpuech-Brugere","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2005.01.004_bib60","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.1993.264.3.C723","article-title":"Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in an Mg-deficient rat model","volume":"264","author":"Weglicki","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.arcmed.2005.01.004_bib61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01457391","article-title":"Neurogenic peptides and the cardiomyopathy of magnesium-deficiency. Effects of substance P-receptor inhibition","volume":"130","author":"Weglicki","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.arcmed.2005.01.004_bib62","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/diacare.26.4.1147","article-title":"Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. A randomized, double-blind controlled trial","volume":"26","author":"Rodriguez-Moran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib63","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ajcn\/55.6.1161","article-title":"Daily magnesium supplements improve glucose handling in elderly subjects","volume":"55","author":"Paolisso","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib64","doi-asserted-by":"crossref","first-page":"S506","DOI":"10.1080\/07315724.2004.10719390","article-title":"Clinical efficacy of magnesium supplementation in patients with type 2 diabetes","volume":"23","author":"Yokota","year":"2004","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib65","first-page":"1510","article-title":"Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type 2) diabetic patients","volume":"78","author":"Paoliso","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2005.01.004_bib66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/diacare.18.2.188","article-title":"Hypomagnesemia in type 2 diabetes. Effect of a 3-month replacement therapy","volume":"18","author":"Eibl","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<503::AID-DIA596>3.0.CO;2-M","article-title":"Oral magnesium supplementation in insulin-requiring type 2 patients","volume":"15","author":"de Valk","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib68","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2337\/diacare.21.5.682","article-title":"The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes","volume":"21","author":"Lima M de","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib69","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diacare.17.5.460","article-title":"Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients","volume":"17","author":"Gullestad","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1262-3636(07)70116-7","article-title":"Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial","volume":"30","author":"Guerrero-Romero","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.arcmed.2005.01.004_bib71","first-page":"3783","article-title":"Effect of variation in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects","volume":"82","author":"Rosolova","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2005.01.004_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed by 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib73","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2165\/00003495-199754030-00004","article-title":"Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management","volume":"54","author":"Fedele","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.arcmed.2005.01.004_bib74","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1080\/07315724.2001.10719169","article-title":"Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes","volume":"20","author":"Ruhe","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib75","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.2337\/diabetes.53.2007.S110","article-title":"Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes","volume":"53","author":"Green","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2005.01.004_bib76","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2005.01.004_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","article-title":"Are oxidative stress-activated signaling pathways mediators of insulin resistance and \u03b2-cell dysfunction?","volume":"52","author":"Evans","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2005.01.004_bib78","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2005.01.004_bib79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-291X(02)02832-2","article-title":"Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells","volume":"300","author":"Sakai","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2005.01.004_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1464-5491.2000.00259.x","article-title":"Radicals and oxidative stress in diabetes","volume":"17","author":"West","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib81","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ajcn\/52.2.361","article-title":"Vitamin E intakes and sources in the United States","volume":"52","author":"Murphy","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-8223(21)05428-6","article-title":"Vitamin E content of foods","volume":"75","author":"McLaughlin","year":"1979","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.arcmed.2005.01.004_bib83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/hy0202.104345","article-title":"Prevention of hypertension, insulin resistance, and oxidative stress by \u03b1-lipoic acid","volume":"39","author":"El Midaoui","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.arcmed.2005.01.004_bib84","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/diabetes.48.12.2398","article-title":"Beneficial effects of antioxidants in diabetes. Possible protection of pancreatic \u03b2-cells against glucosa toxicity","volume":"48","author":"Kaneto","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2005.01.004_bib85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2337\/diacare.14.1.68","article-title":"Vitamin E reduction of protein glycosylation in diabetes","volume":"14","author":"Cerillo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0735-1097(00)00720-8","article-title":"Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus. A randomized, placebo-controlled study","volume":"36","author":"Andrew","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arcmed.2005.01.004_bib87","first-page":"421","article-title":"Vitamin E modifies neither fructosamine nor HgbA1c levels in poorly controlled diabetes","volume":"48","author":"Gom\u00e9z-P\u00e9rez","year":"1996","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.arcmed.2005.01.004_bib88","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.16.11.1433","article-title":"Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type 2 diabetic patients","volume":"16","author":"Paolisso","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib89","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ajcn\/57.5.650","article-title":"Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients","volume":"57","author":"Paolisso","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib90","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2337\/diacare.18.6.807","article-title":"Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM","volume":"18","author":"Reaven","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8227(99)00010-8","article-title":"Insulin action and fibrinolysis influenced by vitamin E in obese type 2 diabetes mellitus","volume":"4","author":"Skrha","year":"1999","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.arcmed.2005.01.004_bib92","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/07315724.1999.10718883","article-title":"Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus","volume":"18","author":"Anderson","year":"1999","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arcmed.2005.01.004_bib93","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02254975","article-title":"How mitochondrial damage affects cell function","volume":"9","author":"James","year":"2002","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.arcmed.2005.01.004_bib94","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage Vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib95","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s001250051253","article-title":"Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes","volume":"42","author":"Rudich","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2005.01.004_bib96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1054-3589(08)60980-1","article-title":"\u03b1-Lipoic acid. A metabolic antioxidant and potential redox modulator of transcription","volume":"38","author":"Packer","year":"1999","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.arcmed.2005.01.004_bib97","first-page":"298","article-title":"Primary and secondary prevention of atherosclerosis. Is there a role for antioxidants?","volume":"25","author":"Paolisso","year":"1999","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.arcmed.2005.01.004_bib98","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","article-title":"Alpha lipoic acid as a biological antioxidant","volume":"19","author":"Packer","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib99","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0891-5849(99)00011-8","article-title":"Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria","volume":"26","author":"Borcea","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0891-5849(99)00089-1","article-title":"Rett K Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial","volume":"27","author":"Jacob","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.arcmed.2005.01.004_bib101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/jappl.2001.91.1.145","article-title":"Interactions of exercise training and lipoic acid on skeletal muscle transport in obese Zuckert rats","volume":"91","author":"Saengsirisuwan","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.arcmed.2005.01.004_bib102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/diacare.20.3.369","article-title":"Effects of treatment with alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiac Autonome Neuropathie","volume":"20","author":"Ziegler","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib103","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/BF00400603","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)","volume":"38","author":"Ziegler","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2005.01.004_bib104","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2337\/diacare.22.8.1296","article-title":"The ALADIN III Study Group. Treatment of symptomatic diabetic polineuropathy with the antioxidant \u03b1-lipoic acid. A 7-month multicenter randomized controlled trial (ALADIN III Study)","volume":"22","author":"Ziegler","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2337\/diacare.26.3.770","article-title":"The sensory symptoms of diabetic polineuropathy are improved with \u03b1-lipoic acid","volume":"26","author":"Ametov","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2005.01.004_bib106","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0029-1212132","article-title":"Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany. Current evidence from clinical trials","volume":"107","author":"Ziegler","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.arcmed.2005.01.004_bib107","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diacare.27.2.362","article-title":"Dietary antioxidant intake and risk of type 2 diabetes","volume":"27","author":"Montonen","year":"2004","journal-title":"Diabetes Care"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:29:30Z","timestamp":1759260570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440905000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0188440905000056"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.01.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complementary Therapies for Diabetes: The Case for Chromium, Magnesium, and Antioxidants","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}